ImmuCell Price to Book Ratio 2012-2025 | ICCC
Historical price to book ratio values for ImmuCell (ICCC) over the last 10 years. The current price to book ratio for ImmuCell as of February 06, 2026 is 1.89.
| ImmuCell Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2026-02-06 | 6.24 | 1.89 | |
| 2025-09-30 | 6.25 | $3.29 | 1.90 |
| 2025-06-30 | 6.96 | $3.30 | 2.11 |
| 2025-03-31 | 4.79 | $3.23 | 1.48 |
| 2024-12-31 | 5.15 | $3.06 | 1.68 |
| 2024-09-30 | 3.63 | $2.99 | 1.21 |
| 2024-06-30 | 4.85 | $2.99 | 1.62 |
| 2024-03-31 | 5.30 | $3.18 | 1.67 |
| 2023-12-31 | 5.09 | $3.22 | 1.58 |
| 2023-09-30 | 5.34 | $3.36 | 1.59 |
| 2023-06-30 | 5.00 | $3.47 | 1.44 |
| 2023-03-31 | 5.16 | $3.64 | 1.42 |
| 2022-12-31 | 6.10 | $3.92 | 1.56 |
| 2022-09-30 | 7.48 | $4.13 | 1.81 |
| 2022-06-30 | 8.69 | $4.20 | 2.07 |
| 2022-03-31 | 9.65 | $4.28 | 2.25 |
| 2021-12-31 | 8.00 | $4.21 | 1.90 |
| 2021-09-30 | 9.36 | $4.19 | 2.23 |
| 2021-06-30 | 9.50 | $4.17 | 2.28 |
| 2021-03-31 | 9.64 | $3.86 | 2.50 |
| 2020-12-31 | 5.95 | $3.92 | 1.52 |
| 2020-09-30 | 5.43 | $3.88 | 1.40 |
| 2020-06-30 | 4.73 | $3.92 | 1.21 |
| 2020-03-31 | 3.79 | $4.02 | 0.94 |
| 2019-12-31 | 5.15 | $4.02 | 1.28 |
| 2019-09-30 | 5.57 | $4.05 | 1.38 |
| 2019-06-30 | 6.50 | $4.11 | 1.58 |
| 2019-03-31 | 6.35 | $4.20 | 1.51 |
| 2018-12-31 | 7.05 | $3.90 | 1.80 |
| 2018-09-30 | 8.33 | $4.13 | 2.02 |
| 2018-06-30 | 6.82 | $4.16 | 1.64 |
| 2018-03-31 | 7.00 | $4.29 | 1.63 |
| 2017-12-31 | 8.79 | $4.31 | 2.04 |
| 2017-09-30 | 6.50 | $4.15 | 1.57 |
| 2017-06-30 | 7.33 | $4.17 | 1.76 |
| 2017-03-31 | 5.53 | $4.20 | 1.32 |
| 2016-12-31 | 5.95 | $4.07 | 1.46 |
| 2016-09-30 | 7.73 | $3.74 | 2.07 |
| 2016-06-30 | 6.90 | $3.72 | 1.86 |
| 2016-03-31 | 6.85 | $3.91 | 1.75 |
| 2015-12-31 | 7.54 | $3.47 | 2.17 |
| 2015-09-30 | 5.95 | $3.37 | 1.77 |
| 2015-06-30 | 7.85 | $3.26 | 2.41 |
| 2015-03-31 | 6.29 | $3.22 | 1.95 |
| 2014-12-31 | 4.86 | $3.06 | 1.59 |
| 2014-09-30 | 4.97 | $3.01 | 1.65 |
| 2014-06-30 | 4.40 | $3.01 | 1.46 |
| 2014-03-31 | 4.80 | $3.10 | 1.55 |
| 2013-12-31 | 4.27 | $3.11 | 1.37 |
| 2013-09-30 | 4.73 | $3.15 | 1.50 |
| 2013-06-30 | 3.76 | $2.96 | 1.27 |
| 2013-03-31 | 3.68 | $3.12 | 1.18 |
| 2012-12-31 | 4.00 | $3.05 | 1.31 |
| 2012-09-30 | 5.11 | $3.05 | 1.68 |
| 2012-06-30 | 5.85 | $3.07 | 1.91 |
| 2012-03-31 | 5.42 | $3.06 | 1.77 |
| 2011-12-31 | 4.65 | $3.00 | 1.55 |
| 2011-09-30 | 5.30 | 0.00 | |
| 2011-06-30 | 7.90 | 0.00 | |
| 2011-03-31 | 3.43 | 0.00 | |
| 2010-12-31 | 3.20 | 0.00 | |
| 2010-09-30 | 3.20 | 0.00 | |
| 2010-06-30 | 3.37 | 0.00 | |
| 2010-03-31 | 3.51 | 0.00 | |
| 2009-12-31 | 3.71 | 0.00 | |
| 2009-09-30 | 3.58 | 0.00 | |
| 2009-06-30 | 2.48 | 0.00 | |
| 2009-03-31 | 1.90 | 0.00 | |
| 2008-12-31 | 1.66 | 0.00 | |
| 2008-09-30 | 3.18 | 0.00 | |
| 2008-06-30 | 3.47 | 0.00 | |
| 2008-03-31 | 3.44 | 0.00 | |
| 2007-12-31 | 3.55 | 0.00 | |
| 2007-09-30 | 4.30 | 0.00 | |
| 2007-06-30 | 5.99 | 0.00 | |
| 2007-03-31 | 5.43 | 0.00 | |
| 2006-12-31 | 5.95 | 0.00 | |
| 2006-09-30 | 4.93 | 0.00 | |
| 2006-06-30 | 4.98 | 0.00 | |
| 2006-03-31 | 6.77 | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.056B | $0.026B |
| ImmuCell Corp. is a biotechnology company striving to build shareholder value by commercializing proprietary technologies and helping dairy and beef producers and their veterinarians manage disease and reproduction in their herds. The company is also conducting an open label, efficacy study of DiffGAM, a human application of its milk-derived passive antibodytechnology for use as an alternative to antibiotics in the treatment and/or prevention of Clostridium difficile-associated diarrhea. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $192.719B | 21.52 |
| EssilorLuxottica (ESLOY) | France | $140.970B | 0.00 |
| Stryker (SYK) | United States | $137.019B | 26.29 |
| Medtronic (MDT) | Ireland | $131.919B | 18.28 |
| Boston Scientific (BSX) | United States | $113.066B | 25.01 |
| Medline (MDLN) | United States | $62.139B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.969B | 0.00 |
| ResMed (RMD) | United States | $39.571B | 26.42 |
| GE HealthCare Technologies (GEHC) | United States | $36.756B | 17.61 |
| Agilent Technologies (A) | United States | $36.736B | 23.22 |
| Koninklijke Philips (PHG) | Netherlands | $28.368B | 18.53 |
| Terumo (TRUMY) | Japan | $19.441B | 21.97 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.819B | 11.11 |
| Insulet (PODD) | United States | $17.019B | 52.82 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.739B | 0.00 |
| Baxter (BAX) | United States | $11.170B | 9.02 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.133B | 29.24 |
| Demant (WILYY) | Denmark | $6.521B | 0.00 |
| Envista Holdings (NVST) | United States | $4.785B | 24.25 |
| Lantheus Holdings (LNTH) | United States | $4.303B | 13.11 |
| BillionToOne (BLLN) | United States | $4.147B | 0.00 |
| ICU Medical (ICUI) | United States | $3.806B | 24.16 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.263B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.139B | 14.81 |
| Haemonetics (HAE) | United States | $2.758B | 12.06 |
| Neogen (NEOG) | United States | $2.349B | 51.43 |
| Phibro Animal Health (PAHC) | United States | $2.151B | 18.95 |
| Perrigo (PRGO) | Ireland | $2.015B | 5.05 |
| LeMaitre Vascular (LMAT) | United States | $1.983B | 39.92 |
| QuidelOrtho (QDEL) | United States | $1.977B | 12.71 |
| AtriCure (ATRC) | United States | $1.845B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.622B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.486B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.475B | 64.64 |
| AdaptHealth (AHCO) | United States | $1.442B | 20.88 |
| Capricor Therapeutics (CAPR) | United States | $1.130B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.080B | 320.43 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.021B | 0.00 |
| InMode (INMD) | Israel | $0.953B | 10.77 |
| Tilray Brands (TLRY) | Canada | $0.883B | 0.00 |
| Valneva SE (VALN) | France | $0.817B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.803B | 0.00 |
| Omeros (OMER) | United States | $0.796B | 0.00 |
| CeriBell (CBLL) | United States | $0.747B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.587B | 15.91 |
| Verano Holdings (VRNO) | United States | $0.454B | 0.00 |
| Brainsway (BWAY) | Israel | $0.427B | 72.60 |
| Cerus (CERS) | United States | $0.423B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.405B | 0.00 |
| SNDL (SNDL) | Canada | $0.389B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.377B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.328B | 26.18 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Evolus (EOLS) | United States | $0.292B | 0.00 |
| Quanterix (QTRX) | United States | $0.284B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.237B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.222B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| TerrAscend (TSNDF) | Canada | $0.208B | 0.00 |
| Organigram Global (OGI) | Canada | $0.207B | 0.00 |
| High Tide (HITI) | Canada | $0.207B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.197B | 17.71 |
| Aurora Cannabis (ACB) | Canada | $0.197B | 58.00 |
| OraSure Technologies (OSUR) | United States | $0.194B | 0.00 |
| Accendra Health (ACH) | United States | $0.185B | 1.85 |
| Sanara MedTech (SMTI) | United States | $0.180B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.179B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.148B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.144B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.136B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.72 |
| MacroGenics (MGNX) | United States | $0.115B | 0.00 |
| Biote (BTMD) | United States | $0.102B | 4.46 |
| Jushi Holdings (JUSHF) | United States | $0.100B | 0.00 |
| Exagen (XGN) | United States | $0.080B | 0.00 |
| Sharps Technology (STSS) | United States | $0.048B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.042B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.042B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 29.77 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Modular Medical (MODD) | United States | $0.034B | 0.00 |
| United-Guardian (UG) | United States | $0.033B | 16.63 |
| Jin Medical (ZJYL) | China | $0.022B | 0.00 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |